Home › Marginal Zone Lymphoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Marginal Zone Lymphoma sa Boston, MA

9 pag-aaral para sa Marginal Zone Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Boston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Nagre-recruitPhase 2

Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston
Beth Israel Deaconess Medical Center (Data Collection Only), Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07231952

Epco, Zanu, Ritux for R/R FL or MZL

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06563596

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 16, 2026 · NCT06026319

Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06510309

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

Beth Israel Deaconess Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT04669171

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

Nagre-recruitPhase 2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 5, 2025 · NCT06986174

Pag-aaral para sa Marginal Zone Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.